TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ARAY

Accuray Incorporated

Healthcare · Medical Devices

0.2739$ +4.5% vs. previous close Closing price · As of: Aug 28, 2026

Statements

Segments

US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Accuray Incorporated (ARAY). It shows which part of the business is growing — and which one is holding it back.

Revenue by region

Revenue by region — ARAY
Segment 2021 2022 2023 2024 2025 2026
EIMEA $144.3M 31.5% $150.9M 37.5% · +4.6%
Americas $105.9M 26.7% $126.0M 29.3% · +19.0% $122.3M 27.3% · -2.9% $90.2M 20.2% · -26.3% $88.8M 19.4% · -1.5% $90.0M 22.4% · +1.3%
China $79.8M 20.1% $86.9M 20.2% · +9.0% $75.8M 16.9% · -12.9% $103.4M 23.2% · +36.5% $124.5M 27.1% · +20.4% $68.1M 17.0% · -45.3%
Asia Pacific $28.7M 6.4% $47.4M 10.3% · +65.1% $48.7M 12.1% · +2.7%
Japan $62.6M 15.8% $53.4M 12.4% · -14.8% $62.0M 13.8% · +16.1% $55.7M 12.5% · -10.1% $53.6M 11.7% · -3.7% $44.3M 11.0% · -17.5%
Asia Pacific, excluding Japan and China $26.4M 6.7%
Europe, India, Middle East and Africa $121.6M 30.7% $134.6M 31.3% · +10.8% $155.9M 34.8% · +15.8% $168.6M 37.8% · +8.2%
Asia Pacific, excluding China $29.0M 6.7% $31.7M 7.1% · +9.4%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Revenue by product line

Revenue by product line — ARAY
Segment 2021 2022 2023 2024 2025 2026
Services $219.6M 55.4% $215.2M 50.1% · -2.0% $214.4M 47.9% · -0.4% $212.4M 47.6% · -0.9% $220.9M 48.2% · +4.0% $229.2M 57.0% · +3.8%
Products $176.6M 44.6% $214.7M 49.9% · +21.6% $233.2M 52.1% · +8.6% $234.2M 52.4% · +0.4% $237.6M 51.8% · +1.5% $172.7M 43.0% · -27.3%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.

Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?